AI assistant
SURMODICS INC — Director's Dealing 2019
Dec 4, 2019
32845_dirs_2019-12-04_bd6acab8-9561-426a-a587-17fd50c68af7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2019-12-02
Reporting Person: Maharaj Gary R (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-12-02 | Common Stock | S | 4270 | $40.3303 | Disposed | 144317 | Direct |
| 2019-12-02 | Common Stock | S | 730 | $40.7437 | Disposed | 143587 | Direct |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019.
F2: Reflects the weighted average price of 4,270 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on December 2, 2019 with sale prices ranging from $39.725 to $40.67 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Reflects the weighted average price of 730 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on December 2, 2019 with sale prices ranging from $40.725 to $40.88 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.